RxSight

RxSight General Information

RxSight’s Light Adjustable Lens system has demonstrated superior visual outcomes in clinical studies. In a prospective, controlled multicenter study of 600 patients, 92% of eyes achieved results within 0.50 diopters of target manifest refraction spherical equivalent at six months. Patients were approximately twice as likely to achieve 20/20 vision or better without glasses compared to controls with standard monofocal IOLs. The product offers LASIK-like accuracy for cataract patients and corrects as low as 0.50 D of astigmatism—the lowest level approved for treatment.

Contact Information